# Nalmefene in Alcohol Dependence and Borderline Personality Disorder

> **NCT02752503** · NA · UNKNOWN · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 30 (estimated)

## Conditions studied

- Alcohol Use Disorder
- Borderline Personality Disorder

## Interventions

- **DRUG:** Nalmefene

## Key facts

- **NCT ID:** NCT02752503
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2016-06
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02752503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02752503, "Nalmefene in Alcohol Dependence and Borderline Personality Disorder". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02752503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*